Recon: EMA recommends Novo’s Wegovy for heart risks; Mankind to buy Bharat Serums for $1.6B
ReconJason Scott
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States